Free alert and updates

Register for free Alerts & Updates

Test our services

To start your trial

Monthly Offer

OUR SPECIAL OFFER

Live chat

Verified By

Merchant account,
Credit Card Processing
Payment Gateway

Special Equity Intraday Package

Date Scrip Name Buy Or Sell Enter Price Target SL Result No. of Shares Total Profits
01-Apr Cairn Buy 351 355 349 Target Hitted 1500 6000
04-Apr GTLINFRA Buy 37 38.1 36 Target Hitted 10000 11000
05-Apr Ashokley Sell 59.5 58 134.5 Target Hitted 10000 15000
06-Apr Dabur Buy 98 100 97 Target Hitted 10000 20000
07-Apr Zeel Sell 129 125 131 Target Hitted 5000 20000
08-Apr Rolta Sell 156 152 158 Target Hitted 5000 20000
11-Apr ALBK Buy 220 225 218 Target Hitted 1500 7500
13-Apr IDBI Buy 143 147 141 Target Hitted 1500 6000
15-Apr Escorts Sell 140 137 142 Target Hitted 1500 4500
18-Apr ACC Sell 1115 1099 1122 Target Hitted 500 8000
20-Apr Ster Buy 172 174 171 Sl Hitted 2000 -2000
21-Apr Suzlon Sell 58 57 58.5 Target Hitted 10000 10000
25-Apr Bhel Buy 2075 2094 2064 Target Hitted 500 9500
26-Apr Hindzinc Sell 153 147 155 Booked@ 148 5000 25000
27-Apr Polaris Sell 214 209 216 Target Hitted 1500 7500
28-Apr HDFC Sell 715 709 719 Target Hitted 1500 9000
29-Apr Oriental Bank Sell 367 349 375 Target Hitted 1500 27000
Total Profit Rs 2,04,000

Special Equity Intraday Package

  • Above 90% maintained on Monthly Average Basis.
  • Daily 2-3 Tips or monthly 40-50 Tips

Special Equity Intraday Package

Disclaimer

Disclaimer: These recommendations are based on the theory of technical analysis and personal observations. This does not claim for profit. We are not responsible for any losses made by traders. It is only the outlook of the market with reference to its previous performance. You are advised to take your position with your sense and judgment. We are trying to consider the fundamental validity of stocks as far as possible, but demand and supply affects it with vision variations. If any other company also giving same script and recommandation then we are not responsible for that. We have not any position in our given scripts. Visiting our web one should by agree to our terms and condition and disclaimer also.

Protected by Copyscape Duplicate Content Check